Josh Hamilton,

DNP, APRN-BC, CTMH, CNE, CLNC, FAANP

Josh Hamilton,

DNP, APRN-BC, CTMH, CNE, CLNC, FAANP

Josh Hamilton,

DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University

Josh Hamilton, DNP, APRN-BC, CTMH, CNE, CLNC, FAANP, is in private practice in Las Vegas, where he serves patients via telebehavioral health in more than six states. With more than two decades of nursing experience, he also holds professorial appointments, leadership positions, and consults in higher education. Previously, he was associate medical director for the largest managed care behavioral health network in the desert Southwest. His professional interests include neurobiology, pharmacology, and epigenetics. He is an internationally recognized speaker on these and related topics at conferences and professional meetings. He served on the psychiatric medication working group at the Center of Excellence in Regulatory Science and Innovation, a FDA-sponsored project at the University of Maryland. He is a NEI Master Psychopharmacologist and a fellow of the American Association of Nurse Practitioners. Josh was America’s Top Psychiatric NP in 2021.

Josh's Shared Resources

Schizophrenia: Pathogenesis, Genetics, and Clinical Advances

Schizophrenia is a debilitating neurological disorder characterized by chronic psychotic symptoms and significant psychosocial impairment. Its etiology involves complex interactions...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Empowering Families: Relapse Prevention in Schizophrenia Care

Schizophrenia is a severe mental disorder affecting millions globally, characterized by delusions, hallucinations, and cognitive deficits, leading to psychosocial challenges...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Preventing Relapse and Hospitalization in Schizophrenia

The prevention of relapse and hospitalization in schizophrenia is a significant public health challenge. Antipsychotic medications reduce relapse risk, with...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Mindfulness-Based Interventions in Schizophrenia

A review of 22 randomized controlled trials involving 1500 patients with schizophrenia spectrum disorder explored the use of mindfulness-based interventions...
CURATED BY:
Sarah Ann Scantamburlo,
MSW, MS, PA-C

Emerging Treatments for Schizophrenia: Addressing Gaps in Symptom Management and Adherence Challenges

Schizophrenia is a severe condition treated primarily with dopamine-modulating antipsychotics, which mainly address positive symptoms but often fail to manage...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Predictors of Medication Response in Treatment-Resistant Schizophrenia

A study aimed to identify predictors of medication response in treatment-resistant schizophrenia (TRS) by analyzing baseline patient and study characteristics...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP
Share